Form 4: Ingevity Executive Granted 1,389 Restricted Stock Units

Ingevity Corporation's SVP and President of APT, Michael N. Shukov, was granted 1,389 restricted stock units vesting over three years.

Summary

• Michael N. Shukov, SVP and President of APT at Ingevity Corp (NGVT), was granted 1,389 shares of common stock.
• The shares were granted as restricted stock units (RSUs) under the Ingevity Corporation 2025 Omnibus Incentive Plan.
• These RSUs will vest in three equal installments on February 27, 2027, February 27, 2028, and February 27, 2029.
• The transaction date for the grant was February 27, 2026, with a reported price of $0 per share.
• Following this transaction, Michael N. Shukov beneficially owns 1,389 shares directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a routine and generally positive event, as it signifies ongoing executive commitment and aligns management's interests with long-term company performance, without indicating any immediate operational or financial changes.

Positives

• The grant of restricted stock units aligns management's interests with long-term shareholder value creation.
• The vesting schedule over three years encourages executive retention and sustained performance.

Future Outlook

The vesting schedule for the restricted stock units indicates a future commitment to the company by the executive, aligning with long-term performance incentives.

Industry Context

StockSavvy.ai notes that executive equity grants, particularly restricted stock units with multi-year vesting, are a common practice across industries to incentivize long-term performance and align executive interests with shareholder value. This grant to a key executive at Ingevity reflects standard corporate governance practices for executive compensation.

Comparison to Industry Standards

• This RSU grant is consistent with common executive compensation practices in the specialty chemicals and materials industry, where companies like DuPont, Eastman Chemical, and Albemarle frequently use similar long-term incentive plans to retain and motivate key personnel.
• The three-year vesting schedule is a standard approach to encourage sustained performance.

Corporate Governance

Stakeholder Impact

• Shareholders: Potentially positive, as executive incentives are aligned with long-term company performance.
• Employees: No direct impact on general employees, but may signal stability in executive leadership.

Next Steps

• The restricted stock units will vest in three equal installments on February 27, 2027, 2028, and 2029.

Key Dates

Recommendation

This Form 4 filing reports a routine executive equity grant, which is a standard practice for executive compensation and retention. It does not provide new information that would fundamentally alter the investment thesis for Ingevity, thus a 'hold' recommendation is appropriate as it maintains existing positions without suggesting new buying or selling activity based solely on this filing.

Keywords

Ingevity, NGVT, Michael Shukov, Restricted Stock Units, RSU Grant, Executive Compensation, Insider Transaction, Form 4, Equity Award